Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bora Lim

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Nature|November 20, 2024
Normal breast tissues harbour rare populations of aneuploid epithelial cellsYiyun Lin, Junke Wang, Kaile Wang, et al.
Cancer|March 27, 2018
Development of CNS metastases and survival in patients with inflammatory breast cancerMarc I Uemura, John T French, Kenneth R Hess, et al.
European Journal of Radiology|April 22, 2019
Imaging features of triple-negative breast cancers according to androgen receptor statusRosalind P Candelaria, Beatriz E Adrada, Wei Wei, et al.
Clinical Breast Cancer|August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution ExperienceRashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.
Molecular Cell|January 14, 2026
Delineating the copy-number substructure of metastatic tumors with CopyKitJunke Wang, Darlan Conterno Minussi, Alexander Davis, et al.
Nature Cell Biology|September 12, 2024
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactionsXiaoxin Hao, Yichao Shen, Jun Liu, et al.
Therapeutic Advances in Medical Oncology|October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)Bora Lim, Angela Marx, Megumi Kai, et al.
Clinical Colorectal Cancer|September 25, 2020
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal CancerArthur Winer, Crystal S Denlinger, Namrata Vijayvergia, et al.
Plos One|October 13, 2018
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtypeKenichi Harano, Ying Wang, Bora Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2021
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast CancerBora Lim, David A Potter, Mohamad A Salkeni, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Nature|November 20, 2024
Normal breast tissues harbour rare populations of aneuploid epithelial cellsYiyun Lin, Junke Wang, Kaile Wang, et al.
Cancer|March 27, 2018
Development of CNS metastases and survival in patients with inflammatory breast cancerMarc I Uemura, John T French, Kenneth R Hess, et al.
European Journal of Radiology|April 22, 2019
Imaging features of triple-negative breast cancers according to androgen receptor statusRosalind P Candelaria, Beatriz E Adrada, Wei Wei, et al.
Clinical Breast Cancer|August 6, 2018
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution ExperienceRashmi K Murthy, Akshara S Raghavendra, Kenneth R Hess, et al.
Molecular Cell|January 14, 2026
Delineating the copy-number substructure of metastatic tumors with CopyKitJunke Wang, Darlan Conterno Minussi, Alexander Davis, et al.
Nature Cell Biology|September 12, 2024
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactionsXiaoxin Hao, Yichao Shen, Jun Liu, et al.
Therapeutic Advances in Medical Oncology|October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)Bora Lim, Angela Marx, Megumi Kai, et al.
Clinical Colorectal Cancer|September 25, 2020
First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal CancerArthur Winer, Crystal S Denlinger, Namrata Vijayvergia, et al.
Plos One|October 13, 2018
Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtypeKenichi Harano, Ying Wang, Bora Lim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2021
Sapanisertib Plus Exemestane or Fulvestrant in Women with Hormone Receptor-Positive/HER2-Negative Advanced or Metastatic Breast CancerBora Lim, David A Potter, Mohamad A Salkeni, et al.
Pageof 15